infliximab biosimilars
Patients Report Satisfaction Switching From Infliximab to Biosimilars
Most patients with IBD who switch from infliximab to an infliximab biosimilar report a positive experience, ...
OCTOBER 29, 2024
Report From CCC 2023: Switching to Infliximab Biosimilar Safe for Adolescents, Young Adults With IBD
Adolescents and young adults with inflammatory bowel disease can switch from the originator to a biosimilar of ...
JANUARY 20, 2023
Load more